Company · CIK 0001211583 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq
FENNEC PHARMACEUTICALS INC. · FENC
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 SForm 4 → | Sep 16, 4:05 pm EDT | Marco Maria BrugheraDirector | 15,545 | $10.29 | $159,958 | 0 | −100% | 10b5-1 |
| Sep 15, 2026 MForm 4 → | Sep 16, 4:05 pm EDT | Marco Maria BrugheraDirector | 15,545 | $2.11 | $32,800 | 15,545 | — | 10b5-1 |
| Sep 1, 2026 SForm 4 → | Sep 1, 4:05 pm EDT | Rosty RaykovOther | 10,000 | $12.11 | $121,100 | 124,411 | −7.44% | 10b5-1 |
| Aug 31, 2026 AForm 4 → | Sep 1, 4:05 pm EDT | Rosty RaykovOther | 2,778 | — | — | 134,411 | — | 10b5-1 |
| Aug 31, 2026 SForm 4 → | Aug 31, 8:15 pm EDT | Pierre Sargis SayadChief Medical Officer | 12,000 | $12.18 | $146,160 | 9,519 | −55.8% | |
| Aug 31, 2026 AForm 4 → | Aug 31, 8:15 pm EDT | Pierre Sargis SayadChief Medical Officer | 168 | — | — | 21,519 | — | |
| Aug 31, 2026 AForm 4 → | Aug 31, 8:13 pm EDT | Terry L EvansChief Commercial Officer | 168 | — | — | 21,519 | — | |
| Aug 31, 2026 AForm 4 → | Aug 31, 8:12 pm EDT | Christiana Marie CioffiChief Strategy Officer | 156 | — | — | 24,644 | — | |
| Aug 31, 2026 AForm 4 → | Aug 31, 8:10 pm EDT | Jeffrey S. HackmanChief Executive Officer, Director | 1,159 | — | — | 66,302 | — | |
| Aug 31, 2026 AForm 4 → | Aug 31, 8:09 pm EDT | Robert AndradeCHIEF FINANCIAL OFFICER | 1,703 | — | — | 241,306 | — | |
| Aug 28, 2026 MForm 4 → | Aug 28, 5:42 pm EDT | Robert AndradeCHIEF FINANCIAL OFFICER | 21,928 | $5.10 | $111,833 | 239,603 | — | 10b5-1 |
| Aug 27, 2026 SForm 4 → | Aug 28, 5:42 pm EDT | Robert AndradeCHIEF FINANCIAL OFFICER | 75,000 | $11.78 | $883,500 | 217,675 | −25.6% | 10b5-1 |
| Aug 3, 2026 SForm 4 → | Aug 4, 4:05 pm EDT | Rosty RaykovOther | 10,000 | $9.58 | $95,800 | 131,633 | −7.06% | 10b5-1 |
| Jul 31, 2026 AForm 4 → | Aug 3, 4:05 pm EDT | Pierre Sargis SayadChief Medical Officer | 168 | — | — | 21,351 | — | |
| Jul 31, 2026 AForm 4 → | Aug 3, 4:05 pm EDT | Terry L EvansChief Commercial Officer | 168 | — | — | 21,351 | — | |
| Jul 31, 2026 AForm 4 → | Aug 3, 4:05 pm EDT | Christiana Marie CioffiChief Strategy Officer | 156 | — | — | 24,488 | — | |
| Jul 31, 2026 AForm 4 → | Aug 3, 4:05 pm EDT | Jeffrey S. HackmanChief Executive Officer, Director | 1,159 | — | — | 65,143 | — | |
| Jul 31, 2026 AForm 4 → | Aug 3, 4:05 pm EDT | Rosty RaykovOther | 2,778 | — | — | 141,633 | — | |
| Jul 31, 2026 AForm 4 → | Aug 3, 4:05 pm EDT | Robert AndradeCHIEF FINANCIAL OFFICER | 1,703 | — | — | 292,675 | — | |
| Jul 1, 2026 SForm 4 → | Jul 2, 4:05 pm EDT | Rosty RaykovOther | 9,599 | $10.41 | $99,926 | 138,855 | −6.47% | 10b5-1 |
| Jul 1, 2026 AMForm 4 → | Jul 2, 4:05 pm EDT | Rosty RaykovOther | 18,375 | $2.45 | $38,213 | 148,454 | — | 10b5-1 |
| Jun 30, 2026 AForm 4 → | Jul 1, 4:38 pm EDT | Terry L EvansChief Commercial Officer | 168 | — | — | 21,183 | — | |
| Jun 30, 2026 AForm 4 → | Jul 1, 4:37 pm EDT | Pierre Sargis SayadChief Medical Officer | 168 | — | — | 21,183 | — | |
| Jun 30, 2026 AForm 4 → | Jul 1, 4:36 pm EDT | Jeffrey S. HackmanChief Executive Officer, Director | 1,159 | — | — | 63,984 | — | |
| Jun 30, 2026 AForm 4 → | Jul 1, 4:35 pm EDT | Robert AndradeCHIEF FINANCIAL OFFICER | 1,703 | — | — | 290,972 | — | |
| Jun 30, 2026 AForm 4 → | Jul 1, 4:34 pm EDT | Christiana Marie CioffiChief Strategy Officer | 156 | — | — | 24,332 | — | |
| Aug 20, 2018 MForm 4/A → | Aug 22, 7:46 pm EDT | Rosty RaykovChief Executive Officer, Director | 17,050 | $1.44 | $24,552 | 57,790 | — | plan? |
| Aug 20, 2018 MForm 4 → | Aug 21, 3:09 pm EDT | Rosty RaykovChief Executive Officer | 17,050 | $1.44 | $24,552 | 40,470 | — | plan? amended |
| Aug 15, 2018 MForm 4 → | Aug 17, 4:33 pm EDT | Robert AndradeChief Financial Officer | 17,050 | $1.44 | $24,552 | 17,050 | — | plan? |
| Mar 8, 2018 SForm 4 → | Mar 29, 5:10 pm EDT | MANCHESTER MANAGEMENT PR, LLC +410% Owner | 914,745 | $10.61 | $9,704,023 | 1,250,000 | −42.3% | plan? late |
| Dec 12, 2017 PForm 4 → | Dec 14, 4:15 pm EST | Essetifin SPA +510% Owner | 294,115 | $8.50 | $2,499,978 | 3,225,694 | +10.0% | plan? |
| Apr 12, 2017 SForm 4 → | Mar 29, 2018, 5:07 pm EDT | MANCHESTER MANAGEMENT PR, LLC +410% Owner | 70,100 | $9.22 | $646,577 | 2,156,797 | −3.15% | plan? late |
| Feb 28, 2017 PForm 4 → | Mar 29, 2018, 5:07 pm EDT | MANCHESTER MANAGEMENT PR, LLC +410% Owner | 79,830 | $7.28 | $581,310 | 1,674,614 | +5.01% | plan? late |
| Aug 23, 2016 PForm 4 → | Mar 29, 2018, 5:03 pm EDT | MANCHESTER MANAGEMENT PR, LLC +410% Owner | 96,000 | $2.01 | $192,640 | 1,634,899 | +6.24% | plan? late |
| Jan 27, 2016 PForm 4 → | Mar 29, 2018, 4:59 pm EDT | MANCHESTER MANAGEMENT PR, LLC +410% Owner | 190,850 | $2.06 | $392,528 | 1,586,899 | +13.7% | plan? late |
| Dec 29, 2015 PForm 4 → | Mar 29, 2018, 4:51 pm EDT | MANCHESTER MANAGEMENT CO LLC +310% Owner | 40,600 | $1.78 | $72,304 | 1,491,474 | +2.80% | plan? late |
| May 27, 2015 PForm 4 → | Mar 29, 2018, 4:48 pm EDT | MANCHESTER MANAGEMENT CO LLC +310% Owner | 102,960 | $1.65 | $170,046 | 1,471,174 | +7.53% | plan? late |
| Dec 24, 2014 PForm 4 → | Mar 29, 2018, 4:47 pm EDT | MANCHESTER MANAGEMENT CO LLC +310% Owner | 189,800 | $2.51 | $475,668 | 1,419,694 | +15.4% | plan? late |
| Aug 29, 2014 PForm 4 → | Mar 29, 2018, 4:45 pm EDT | MANCHESTER MANAGEMENT CO LLC +310% Owner | 82,666 | $2.48 | $205,132 | 1,324,794 | +6.66% | plan? late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 15, 2026 MForm 4 → | Sep 16, 4:05 pm EDT | Marco Maria BrugheraDirector | 15,545 | — | — | 220,000 | — | 10b5-1 |
| Aug 28, 2026 MForm 4 → | Aug 28, 5:42 pm EDT | Robert AndradeCHIEF FINANCIAL OFFICER | 21,928 | — | — | 779,330 | — | 10b5-1 |
| Jul 1, 2026 MForm 4 → | Jul 2, 4:05 pm EDT | Rosty RaykovOther | 15,597 | $2.45 | $38,213 | 1,525,000 | — | 10b5-1 |
| Jun 10, 2026 AForm 4 → | Jun 10, 5:50 pm EDT | Marco Maria BrugheraDirector | 20,000 | $8.70 | $174,000 | 235,545 | — | |
| Jun 10, 2026 AForm 4 → | Jun 10, 5:27 pm EDT | Jodi A CookDirector | 20,000 | $8.70 | $174,000 | 160,000 | — | |
| Jun 10, 2026 AForm 4 → | Jun 10, 5:26 pm EDT | Khalid IslamDirector | 25,000 | $8.70 | $217,500 | 250,000 | — | |
| Jun 10, 2026 AForm 4 → | Jun 10, 5:24 pm EDT | Chris A RallisDirector | 20,000 | $8.70 | $174,000 | 200,000 | — | |
| Jun 8, 2018 AForm 4 → | Jun 11, 10:44 am EDT | Khalid IslamDirector | 25,000 | — | — | 25,000 | — | |
| Jun 8, 2018 AForm 4 → | Jun 11, 10:43 am EDT | Adrian HaighDirector | 20,000 | — | — | 20,000 | — | |
| Jun 8, 2018 AForm 4 → | Jun 11, 10:41 am EDT | Marco Maria BrugheraDirector | 20,000 | — | — | 20,000 | — | |
| Jun 8, 2018 AForm 4 → | Jun 11, 10:40 am EDT | Chris A RallisDirector | 20,000 | — | — | 20,000 | — | |
| Feb 6, 2018 AForm 4 → | Feb 8, 9:03 pm EST | Rosty RaykovChief Executive Officer, Director | 100,000 | — | — | 100,000 | — | |
| Feb 6, 2018 AForm 4 → | Feb 8, 9:02 pm EST | Robert AndradeChief Financial Officer | 50,000 | — | — | 50,000 | — |